These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6535712)

  • 21. The inheritance of factors controlling resistance in mice infected with Trypanosoma brucei rhodesiense.
    Seed JR; Sechelski J
    J Parasitol; 1995 Aug; 81(4):653-7. PubMed ID: 7623216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Indirect haemagglutination test with sera of animals experimentally infected with Trypanosoma brucei and T. rhodesiense.
    Woo PT; Soltys MA
    Z Tropenmed Parasitol; 1972 Jun; 23(2):166-72. PubMed ID: 5050539
    [No Abstract]   [Full Text] [Related]  

  • 23. B lymphocytes of mice display an aberrant activation phenotype and are cell cycle arrested in G0/G1A during acute infection with Trypanosoma brucei.
    Sacco RE; Hagen M; Donelson JE; Lynch RG
    J Immunol; 1994 Aug; 153(4):1714-23. PubMed ID: 7519210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The trypanolytic factor of human serum.
    Pays E; Vanhollebeke B; Vanhamme L; Paturiaux-Hanocq F; Nolan DP; Pérez-Morga D
    Nat Rev Microbiol; 2006 Jun; 4(6):477-86. PubMed ID: 16710327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lysis of Trypanosoma brucei brucei by human serum.
    Tomlinson S; Raper J
    Nat Biotechnol; 1996 Jun; 14(6):717-21. PubMed ID: 9630977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune complex formation in the kidney: recent observations in experimental trypanosomiasis.
    Bruijn JA; Oemar BS; Ehrich JH; Fleuren GJ
    Ann Soc Belg Med Trop; 1988 Mar; 68(1):11-4. PubMed ID: 3263090
    [No Abstract]   [Full Text] [Related]  

  • 27. Further studies on acquisition of potential infectivity for man in closely related Trypanosoma Trypanozoon brucei clones.
    Joshua RA
    Int J Zoonoses; 1985 Dec; 12(4):291-8. PubMed ID: 3836215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in the sensitivity of successive variable antigen types in a Trypanosoma (Trypanozoon) brucei subspecies clone to some African game animal sera.
    Rickman L; Kolala F; Mwanza S
    Acta Trop; 1981 Jun; 38(2):115-24. PubMed ID: 6115551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A proposed density-dependent model of long slender to short stumpy transformation in the African trypanosomes.
    Seed JR; Black SJ
    J Parasitol; 1997 Aug; 83(4):656-62. PubMed ID: 9267408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental infection with two stocks of Trypanosoma brucei gambiense. Study of the evolution by elution techniques of tissues.
    Mulumba PM; Wéry M
    Contrib Microbiol Immunol; 1983; 7():120-9. PubMed ID: 6825435
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of anti-ganglioside antibody in experimental Trypanosoma brucei infection in mice.
    Tsujimura Y; Watarai S; Uemura A; Ohnishi Y; Kodama H
    Res Vet Sci; 2005 Jun; 78(3):245-7. PubMed ID: 15766944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis.
    Amin DN; Rottenberg ME; Thomsen AR; Mumba D; Fenger C; Kristensson K; Büscher P; Finsen B; Masocha W
    J Infect Dis; 2009 Nov; 200(10):1556-65. PubMed ID: 19827943
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Defense mechanisms in trypanosomiasis].
    Daulouede PS; Okomo-Assoumou MC; Labassa M; Fouquet C; Vincendeau P
    Bull Soc Pathol Exot; 1994; 87(5):330-2. PubMed ID: 7496195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
    Gehrig S; Efferth T
    Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of Grammomys surdaster thicket rats to Trypanosoma brucei gambiense infection.
    Büscher P; Bin Shamamba SK; Ngoyi DM; Pyana P; Baelmans R; Magnus E; Van Overmeir C
    Trop Med Int Health; 2005 Sep; 10(9):850-5. PubMed ID: 16135191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice.
    Kaushik RS; Uzonna JE; Zhang Y; Gordon JR; Tabel H
    Cytokine; 2000 Jul; 12(7):1024-34. PubMed ID: 10880248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Free plasma amino acid profiles of normal and Trypanosoma brucei-infected rats.
    Isoun TT; Isoun MJ
    Acta Trop; 1978 Sep; 35(3):287-90. PubMed ID: 31783
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune protection of birds against a stock of Trypanosoma brucei.
    Joshua RA; Herbert WJ; White RG
    Res Vet Sci; 1982 Sep; 33(2):135-7. PubMed ID: 7146625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of parasitemia and survival during Trypanosoma brucei brucei infection is related to strain-dependent ability to produce IL-4.
    Bakhiet M; Jansson L; Büscher P; Holmdahl R; Kristensson K; Olsson T
    J Immunol; 1996 Oct; 157(8):3518-26. PubMed ID: 8871651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.